Gilead Sciences

Gilead Sciences

Gilead Sciences

Official Twitter feed for news and updates from Gilead Sciences.Gilead's Twitter guidelines can be found here on our site
Type
B2b
Founded
1987
Follow us
Pulse 2.0

Targeted Cancer Therapy Biotech Company Tango Therapeutics Raises $50 Million 

Xconomy

Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor

$50,000,000 Venture capital
FinSMEs

Tango Therapeutics Raises $50M in Equity Financing

$46,700,000 Venture capital (Series B)
MedCity News , FinSMEs

Glympse Bio raises more than $46M in Series B round for biosensor technology

$60,000,000 Venture capital (Series B)
Pulse 2.0

Targeted Cancer Therapies Company Tango Closes $60 Million

$126,400,000 IPO
PE HUB

VC-backed BioSciences goes public

MedCity News

Gilead Sciences, Tango Therapeutics join forces on immuno-oncology

$22,000,000 Venture capital (Series A)
FinSMEs , PE HUB

Glympse Bio Raises $22m Series A Financing

Funding Science
$110,000,000 Venture capital (Series B)
FinSMEs

Precision BioSciences Raises $110M in Series B Funding

Funding
FinSMEs

Tmunity Therapeutics Raises $100M in Series A Financing

Funding Health
$55,000,000 Venture capital (Series A)
businesswire

Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment